KD Logo

Recent Insider Activity Suggests Potential Gains for Viking Therapeutics Inc (VKTX)

Viking Therapeutics Inc’s recent filing unveils that its Chief Financial Officer ZANTE GREG unloaded Company’s shares for reported $4.99 million on May 03 ’24. In the deal valued at $74.69 per share,66,756 shares were sold. As a result of this transaction, ZANTE GREG now holds 174,854 shares worth roughly $9.1 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Mancini Marianna sold 281,425 shares, generating $22,136,474 in total proceeds. Upon selling the shares at $78.66, the Chief Operating Officer now owns 348,508 shares.

Before that, Lian Brian sold 45,000 shares. Viking Therapeutics Inc shares valued at $1,345,500 were divested by the President & CEO at a price of $29.90 per share. As a result of the transaction, Lian Brian now holds 2,139,882 shares, worth roughly $111.32 million.

Raymond James upgraded its Viking Therapeutics Inc [VKTX] rating to a Strong buy from a an Outperform in a research note published on May 16, 2024; the price target was increased to $116 from $115. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who remained covering the stock and in late March has reiterated a ‘”an Outperform”‘ rating for it. Jefferies began covering VKTX with “Buy” recommendation on March 07, 2024. Oppenheimer maintained its rating on February 28, 2024. It rated VKTX as “an Outperform”.

Price Performance Review of VKTX

On Friday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -0.15% to $52.02. Over the last five days, the stock has lost -7.09%. Viking Therapeutics Inc shares have risen nearly 179.53% since the year began. Nevertheless, the stocks have risen 132.34% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $8.28 was recorded on 01/03/24. SMA at 50 days reached $67.28, while 200 days put it at $37.56. A total of 5.05 million shares were traded, compared to the trading of 2.58 million shares in the previous session.

Levels Of Support And Resistance For VKTX Stock

The 24-hour chart illustrates a support level at 49.20, which if violated will result in even more drops to 46.37. On the upside, there is a resistance level at 53.85. A further resistance level may holdings at 55.67. The Relative Strength Index (RSI) on the 14-day chart is 31.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.42%. Stochastics %K at 11.77% indicates the stock is a buying.

Most Popular